In addition, treatment of this insulin resistance with recombinant D-DT improved glucose intolerance caused by obesity, suggesting that the observed low levels of D-DT in these mice are in part responsible for impaired glucose-stimulated insulin secretion [102]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.